← Eichor
Study identifier: NCT07282665 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older

Condition: Clostridioides Difficile Associated Disease  ·  Sponsor: Pfizer

PhasePhase 3
Planned participants32000
Who can joinAll sexes, 65 Years to no upper limit
Healthy volunteersYes

About this study

The purpose of the study is to learn about how effective, safe, and tolerable the Clostridioides difficile (C. difficile) vaccine is in decreasing the number of C. difficile infections (pCDI) in adults 65 years of age or older. The participants will receive either the C. difficile vaccine or placebo (saline). A placebo does not contain any active ingredients. The vaccines will be given as a shot into the upper arm muscle. This study looks at the number of diarrhea (loose stools) events related to a C. difficile infection, so the length of the study can change. If these events happen quickly, the study may finish sooner; if they happen slowly, it could take longer. Sometimes, the study might stop early if the vaccine clearly works or clearly doesn't. Participants will stay in the study until enough events have occurred to answer the main question. On average, each person is expected to take part for up to about three and a half years. During this time, participants will have 3 planned clinical visits and 3 planned phone visits. After these visits, more scheduled clinic visits will happen every year until the end of study. Besides the scheduled study visits, if at any time during the study a participant has 3 or more loose stools in 24 hours, they will be asked to save the next one (the fourth or later) and contact the study site. The study site will check to see if it could be a C. difficile infection. This check may happen at the clinic or through a phone or video call.

This description comes directly from the study's public registry record.

Talk to the study team

Pfizer CT.gov Call Center  ·  1-800-718-1021  ·  ClinicalTrials.gov_Inquiries@pfizer.com

Always discuss trial participation with your own doctor first.

Locations (174)

North Alabama Research CenterAthens, Alabama, United StatesRecruiting
Lakeview Clinical ResearchGuntersville, Alabama, United StatesRecruiting
Medical Affiliated Research CenterHuntsville, Alabama, United StatesRecruiting
Epic Medical Research-Sun CitySun City, Arizona, United StatesRecruiting
Applied Research Center of ArkansasLittle Rock, Arkansas, United StatesRecruiting
Kaiser Permanente Daly CityDaly City, California, United StatesRecruiting
Kaiser Permanente Los Angeles Medical CenterLos Angeles, California, United StatesRecruiting
Kaiser Permanente Oncology Pharmacy #014CLos Angeles, California, United StatesRecruiting
Sacramento VA Medical CenterMather, California, United StatesNot Yet Recruiting
Kaiser Permanente OaklandOakland, California, United StatesRecruiting
Kaiser Permanente Ontario Medical CenterOntario, California, United StatesRecruiting
Southern California Permanente Medical GroupPasadena, California, United StatesRecruiting

+ 162 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07282665